Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 35, 2005 - Issue 5
156
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes

, , , , , & show all
Pages 419-438 | Received 19 Jan 2005, Published online: 22 Sep 2008

References

  • Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F. 1996. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Analytical Biochemistry 236:184–186.
  • Bissell DM, Guzelian PS. 1980. Phenotypic stability of adult rat hepatocytes in primary monolayer culture. Annals of the New York Academy of Sciences 349:85–98.
  • Buetler TM, Bammler TK, Hayes JD, Eaton DL. 1996. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: Implications for human chemointervention. Cancer Research 56:2306–2313.
  • Buetler TM, Gallagher EP, Wang C, Stahl DL, Hayes JD, Eaton DL. 1995. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicology and Applied Pharmacology 135:45–57.
  • Caron JM. 1990. Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Molecular and Cellular Biology 10:1239–1243.
  • De Sousa G, Langouet S, Nicolas F, Lorenzon G, Placidi M, Rahmani R, Guillouzo A. 1996. Increase of cytochrome P-450 1A and glutathione transferase transcripts in cultured hepatocytes from dogs, monkeys, and humans after cryopreservation. Cell Biology and Toxicology 12:351–358.
  • Dunn JC, Tompkins RG, Yarmush ML. 1991. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnology Progress 7:237–245.
  • Dvorak Z, Modriansky M, Pichard-Garcia L, Balaguer P, Vilarem MJ, Ulrichova J, Maurel P, Pascussi JM. 2003. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Molecular Pharmacology 64:160–169.
  • Eaton DL, Bammler TK. 1999. Concise review of the glutathione 5-transferases and their significance to toxicology. Toxicological Sciences 49:156–164.
  • Edwards RJ, Price RJ, Watts PS, Renwick AB, Tredger JM, Boobis AR, Lake BG. 2003. Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metabolism and Disposition 31:282–288.
  • Egner PA, Kensler TW, Prestera T, Talalay P, Libby AH, Joyner HH, Curphey TJ. 1994. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 15:177–181.
  • Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM. 2000. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metabolism and Disposition 28:1222–1230.
  • Fei P, Matwyshyn GA, Rushmore TH, Kong AN. 1996. Transcription regulation of rat glutathione 5-transferase Ya subunit gene expression by chemopreventive agents. Pharmaceutical Research 13:1043–1048.
  • Gibson GG, Plant NJ, Swales KE, Ayrton A, El-Sankary W. 2002. Receptor-dependent transcriptional activation of cytochrome P4503A genes: Induction mechanisms, species differences and interindividual variation in man. Xenobiotica 32:165–206.
  • Greuet J, Pichard L, Ourlin JC, Bonfils C, Domergue J, Le Treut P, Maurel P. 1997. Effect of cell density and epidermal growth factor on the inducible expression of CYP3A and CYP1A genes in human hepatocytes in primary culture. Hepatology 25:1166–1175.
  • Hakkola J, Pelkonen O, Pasanen M, Raunio H. 1998. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: Role in intrauterine toxicity. Critical Reviews in Toxicology 28:35–72.
  • Hamilton GA, Jolley SL, Gilbert D, Coon DJ, Barros S, LeCluyse EL. 2001. Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell and Tissue Research 306:85–99.
  • Hariparsad N, Nallani SC, Sane RS, Buckley DJ, Buckley AR, Desai PB. 2004. Induction of CYP3A4 by efavirenz in primary human hepatocytes: Comparison with rifampin and phenobarbital. Journal of Clinical Pharmacology 44:1273–1281.
  • Hayes JD, Pulford DJ, Ellis EM, McLeod R, James RF, Seidegard J, Mosialou E, Jernstrom B, Neal GE. 1998. Regulation of rat glutathione 5-transferase AS by cancer chemopreventive agents: Mechanisms of inducible resistance to aflatoxin B 1 . Chemico-Biological Interactions 111–112:51–67.
  • Imai K, Sato T, Senoo H. 2000. Adhesion between cells and extracellular matrix with special reference to hepatic stellate cell adhesion to three-dimensional collagen fibers. Cell Structure and Functions 25:329–336.
  • Kensler TW, Groopman JD, Sutter TR, Curphey TJ, Roebuck BD. 1999. Development of cancer chemopreventive agents: oltipraz as a paradigm. Chemical Research in Toxicology 12:113–126.
  • Kessler FK, Ritter JK. 1997. Induction of a rat liver benzo[a]pyrene-trans-7,8-dihydrodiol glucuronidating activity by oltipraz and beta-naphthoflavone. Carcinogenesis 18:107–114.
  • Ko JW, Desta Z, Flockhart DA. 1998. Human N-demethylation of (5)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metabolism and Disposition 26:775–778.
  • Kocarek TA, Schuetz EG, Guzelian PS. 1993. Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on Matrigel. Molecular Pharmacology 43:328–334.
  • Kostrubsky VE, Ramachandran V, Venkataramanan R, Dorko K, Esplen JE, Zhang S, Sinclair JF, Wrighton SA, Strom SC. 1999. The use of human hepatocyte cultures to study the induction of cytochrome P-450. Drug Metabolism and Disposition 27:887–894.
  • Kranendonk M, Carreira F, Theisen P, Laires A, Fisher CW, Rueff J, Estabrook RW, Vermeulen NP. 1999. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1,1A2,2A6,3A4, or 3A5: Catalytic activities and mutagenicity studies. Mutation Research 441:73–83.
  • Krovat BC, Tracy JH, Omiecinski CJ. 2000. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicological Sciences 55:352–360.
  • Labarca C, Paigen K. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344–352.
  • Langouet S, Maheo K, Berthou F, Morel F, Lagadic-Gossman D, Glaise D, Coles B, Ketterer B, Guillouzo A. 1997. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. Carcinogenesis 18:1343–1349.
  • Langouet S, Morel F, Meyer DJ, Fardel O, Corcos L, Ketterer B, Guillouzo A. 1996. A comparison of the effect of inducers on the expression of glutathione 5-transferases in the liver of the intact rat and in hepatocytes in primary culture. Hepatology 23:881–887.
  • Le Ferrec E, Lagadic-Gossmann D, Rauch C, Bardiau C, Maheo K, Massiere F, Le Vee M, Guillouzo A, Morel F. 2002. Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent. Journal of Biological Chemistry 277:24780–24787.
  • LeCluyse EL. 2001. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. European Journal of Pharmaceutical Sciences 13:343–368.
  • LeCluyse E, Bullock P, Madan A, Carroll K, Parkinson A. 1999. Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes. Drug Metabolism and Disposition 27:909–915.
  • LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R, Parkinson A. 2000. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. Journal of Biochemical and Molecular Toxicology 14:177–188.
  • Liu N, Zhang QY, Vakharia D, Dunbar D, Kaminsky LS. 2001. Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2? Archives of Biochemistry and Biophysics 389:130–134.
  • Madan A, Graham RA, Carroll KM, Mudra DR, Burton LA, Krueger LA, Downey AD, Czerwinski M, Forster J, Ribadeneira MD, et al. 2003. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metabolism and Disposition 31:421–431.
  • Maheo K, Antras-Ferry J, Morel F, Langouet S, Guillouzo A. 1997. Modulation of glutathione 5-transferase subunits A2, Ml, P1 expression by interleukin-lbeta in rat hepatocytes in primary culture. Journal of Biological Chemistry 272:16125–16132.
  • Martin H, Sarsat JP, de Waziers I, Housset C, Balladur P, Beaune P, Albaladejo V, Lerche-Langrand C. 2003. Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices. Pharmaceutical Research 20:557–568.
  • Martinez-Hernandez A, Amenta PS. 1993. The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch A Pathological Anatomy and Histopathology 423:1–11.
  • McCarver DG, Hines RN. 2002. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. Journal of Pharmacology and Experimental Therapeutics 300:361–366.
  • Morel F, Fardel O, Meyer DJ, Langouet S, Gilmore KS, Meunier B, Tu CP, Kensler TW, Ketterer B, Guillouzo A. 1993. Preferential increase of glutathione 5-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones. Cancer Research 53:231–234.
  • Murray GI, Melvin WT, Greenlee WF, Burke MD. 2001. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annual Reviews of Pharmacology and Toxicology 41:297–316.
  • Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. 2004. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicology and Applied Pharmacology 199:193–209.
  • Pascussi JM, Busson-Le Coniat M, Maurel P, Vilarem MJ. 2003. Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: Identification of a distal glucocorticoid response element. Molecular Endocrinology 17:42–55.
  • Pulford DJ, Hayes JD. 1996. Characterization of the rat glutathione 5-transferase Yc2 subunit gene, GSTA5: Identification of a putative antioxidant-responsive element in the 5'-flanking region of rat GSTA5 that may mediate chemoprotection against aflatoxin Bl. Biochemical Journal 318(1):75–84.
  • Ren XD, Kiosses WB, Schwartz MA. 1999. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. The EMBO Journal 18:578–585.
  • Rodriguez-Antona C, Jover R, Gomez-Lechon MJ, Castell JV. 2000. Quantitative RT-PCR measurement of human cytochrome P-450s: Application to drug induction studies. Archives of Biochemistry and Biophysics 376:109–116.
  • Schuetz EG, Li D, Omiecinski CJ, Muller-Eberhard U, Kleinman HK, Elswick B, Guzelian PS. 1988. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. Journal of Cellular Physiology 134:309–323.
  • Sidhu JS, Farm FM, Omiecinski CJ. 1993. Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2, and 3A1 genes in primary adult rat hepatocyte culture. Archives of Biochemistry and Biophysics 301:103–113.
  • Sidhu JS, Farm FM, Kavanagh TJ, Omiecinski CJ. 1994. Effect of tissue-culture substratum and extracellular matrix overlay on liver-selective and xenobiotic inducible gene expression in primary rat hepatocytes. In vitro Toxicology 7:225–242.
  • Sidhu JS, Liu F, Omiecinski CJ. 2004. Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: Requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Experimental Cell Research 292:252–264.
  • Silva JM, Morin PE, Day SH, Kennedy BP, Payette P, Rushmore T, Yergey JA, Nicoll-Griffith DA. 1998. Refinement of an in vitro cell model for cytochrome P450 induction. Drug Metabolism and Disposition 26:490–496.
  • Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD, Schuetz EG. 1996. Use of human hepatocytes to study P450 gene induction. Methods in Enzymology 272:388–401.
  • Suzuki T, Smith S, Board PG. 1994. Structure and function of the 5' flanking sequences of the human alpha class glutathione 5-transferase genes. Biochemical and Biophysical Research Communications 200:1665–1671.
  • Wang H, LeCluyse EL. 2003. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clinical Pharmacokinetics 42:1331–1357.
  • Waxman DJ. 1999. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR. Archives of Biochemistry and Biophysics 369:11–23.
  • Whysner J, Ross PM, Williams GM. 1996. Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacology and Therapeutics 71:153–191.
  • Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM. 2000. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes and Development 14:3014–3023.
  • Xu L, Li AP, Kaminski DL, Ruh ME. 2000. 2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes. Chemico-Biological Interactions 124:173–189.
  • Yuan J, Liu L, Shimada M, Wang A, Ruhnke M, Heeckt P, Muller AR, Nussler NC, Neuhaus P, Nussler A. 2004. Induction, expression and maintenance of cytochrome P450 isoforms in long-term cultures of primary human hepatocytes. Altex 21 (Suppl. 3): 3–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.